)
)
)
Recall Therapeutics
Recall Therapeutics is pioneering a breakthrough platform for memory restoration in Alzheimer’s disease, oncology-related cachexia, and aging-associated sarcopenia.
What is your next catalyst (value inflection) update?
Completing NHP study and PreIND FDA meeting
Year Founded
2024
Lead Product in Development
RTX-100 focused on Alzheimer's memory restoration
Development Phase of Lead Product
Pre-Clinical
Number of Unlicensed Products Looking for Licensing
2
CEO/Top Company Official
Dan Salain
When you expect your next catalyst update?
August 2026
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
